crinetics pharmaceuticals san diego logo web
  • Pipeline
    • Research Pipeline
    • Paltusotine
    • CRN04777, Oral SST5 Agonist
    • CRN04894, Oral ACTH Antagonist
    • Oral PTH Antagonist
  • Patients
    • Clinical Trials
    • Patient Videos
      • Clinical Trials
      • Acromegaly in a Pandemic
      • Acromegaly Symptoms
      • Acromegaly Diagnosis
      • Acromegaly Advocate
      • Acromegaly Support
    • PATHFNDR
  • Professionals
    • Acromegaly
    • Congenital Hyperinsulinism
    • Carcinoid Syndrome
    • PATHFNDR
  • Investors
    • Overview
    • Corporate Presentation
    • SEC Filings
    • Stock Information
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Investor Resources
  • About Us
    • Employee Spotlight
    • Community
  • Careers
    • Culture
    • Job Listings
    • Benefits
  • Contact
    • Contact Us
    • Partnering
    • Grants and Funding
https://crinetics.com/wp-content/uploads/2022/01/808-rotation-d3-header-optimized.mp4

Events


Brazilian Congress of Endocrinology and Metabolism


September 3-7, 2022

ENDO 2022


June 11-14, 2022

JMP Securities Life Sciences Conference


June 15, 2022

Crinetics Reviews Phase 1 CRN04894 Multiple-Ascending Dose Data


May 25, 2022

Crinetics Reviews Phase 1 CRN04777 Multiple-Ascending Dose Data


March 30, 2022

More Events >

Media Inquiries

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Subscribe


    The Better Bulletin, our periodic newsletter, helps you stay informed on our work to improve the lives of patients living with rare endocrine diseases.

    Add Me
    Name
    Hidden
    Confirmation(Required)
    This field is for validation purposes and should be left unchanged.
    crinetics logo full uai
    • Pipeline
    • Patients
    • Professionals
    • Press
    • Financials
    • Presentation
    • Events
    • Contact
    • Partnering
    • Careers
    • Culture
    • Job Listings
    • About
    • Terms
    • Privacy

    • Crinetics Facebook
    • Crinetics Twitter
    • Crinetics LinkedIn

    (858) 450-6464 · 10222 Barnes Canyon Road, Building 2, San Diego, CA 92121
    Crinetics Pharmaceuticals, Inc. © 2023 All rights reserved

    crinetics logo full uai

    • Pipeline
    • Patients
    • Professionals
    • Financials
    • Presentation
    • Press
    • Events
    • Careers
    • Culture
    • Job Listings
    • About
    • Contact
    • Partnering
    • Privacy
    • Terms
    • Pipeline
    • Patients
    • Professionals
    • Presentation
    • Partnering
    • Financials
    • Press
    • About
    • Contact
    • Careers
    • Privacy
    • Terms

    • Crinetics Facebook
    • Crinetics Twitter
    • Crinetics LinkedIn

    (858) 450-6464

    10222 Barnes Canyon Road, Building 2,
    San Diego, CA 92121

    Crinetics Pharmaceuticals, Inc.
    © 2023 All rights reserved

    Medical Education Grant Application

    "*" indicates required fields

    MM slash DD slash YYYY
    Address*
    Therapeutic Area (TA)
    Type of Grant

    Key Points for Consideration

    If your request for support is approved, you will be required to enter into a written grant agreement with Crinetics. Crinetics has drafted the terms of its agreement to be balanced, reasonable and to further the goals of both parties. Negotiating grant agreements requires significant resources, so please ensure that your institution is able and willing to abide by standard agreement terms before proceeding with submission of your application as they will need to be accepted to proceed.
    Max. file size: 50 MB.
    Signed and dated on your organization’s letterhead

    Investigator-Initiated Research Study Application

    "*" indicates required fields

    MM slash DD slash YYYY
    Address*
    Therapeutic Area (TA):

    Key points for Consideration

    If your request for support is approved, you will be required to enter into a written grant agreement with Crinetics. Crinetics has drafted the terms of its agreement to be balanced, reasonable and to further the goals of both parties. Negotiating grant agreements requires significant resources, so please ensure that your institution is able and willing to abide by standard agreement terms before proceeding with submission of your application as they will need to be accepted to proceed.
    Max. file size: 50 MB.
    Signed and dated on your organization’s letterhead